Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03983 |
| Species: | Homo sapiens |
| Position : | chr14:77264349-77265491 |
| Year: | 2014 |
| Title: | Genetic determinants of neuroglobin transcription. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Alzheimer disease |
| PMID: | 24362753 |
| MONDO: | MONDO:0004975 |
| Tissue: | brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | human temporal cortex samples |
| Cell Type: | neural cell |
| Cell Ontology ID: | CL:0002319 |
| Experiment Type: | Promoter/enhancer deletion mapping and genetic regulatory analysis; Disease-variant functional analysis |
| High Throughput Method: | Genotyping / expression association |
| Low Throughput Method: | Luciferase reporter; serial deletion analysis; expression analysis |
| Target gene : | NGB |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|